Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Rockwell Medical (RMTI) Accumulated Depreciation & Amortization: 2011-2025

Historic Accumulated Depreciation & Amortization for Rockwell Medical (RMTI) over the last 8 years, with Sep 2025 value amounting to $544,000.

  • Rockwell Medical's Accumulated Depreciation & Amortization rose 0.18% to $544,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 0.09%. This contributed to the annual value of $2.2 million for FY2024, which is 50.97% up from last year.
  • Per Rockwell Medical's latest filing, its Accumulated Depreciation & Amortization stood at $544,000 for Q3 2025, which was down 3.37% from $563,000 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Accumulated Depreciation & Amortization registered a high of $564,000 during Q3 2023, and its lowest value of $133,000 during Q4 2021.
  • Its 3-year average for Accumulated Depreciation & Amortization is $479,091, with a median of $544,000 in 2025.
  • As far as peak fluctuations go, Rockwell Medical's Accumulated Depreciation & Amortization crashed by 39.55% in 2021, and later soared by 294.41% in 2023.
  • Rockwell Medical's Accumulated Depreciation & Amortization (Quarterly) stood at $133,000 in 2021, then grew by 15.79% to $154,000 in 2022, then surged by 257.14% to $550,000 in 2023, then declined by 1.27% to $543,000 in 2024, then grew by 0.18% to $544,000 in 2025.
  • Its Accumulated Depreciation & Amortization was $544,000 in Q3 2025, compared to $563,000 in Q2 2025 and $539,000 in Q1 2025.